Biotech Values

[urche]

SPPI Deja vu?

This SPPI rituxan FOB thing seems like a terrible idea for them and way out of their league. Strikes me as an ego thing for the company and its management to be involved in the arena. They don't have the money or expertise to play the game

This foray for SPPI reminds me of its short-lived strategy to develop Indian generic drugs as a way to fund its once promising drug, satraplatin.